Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Arthritis Research & Therapy|August 26, 2015
Expression of Semaphorin 4A and its potential role in rheumatoid arthritisLin Wang, Guanhua Song, Yabing Zheng, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 29, 2026
A Relative Bioavailability Study of Vepdegestrant Tablets in Healthy Adult ParticipantsDerek Z Yang, Kyle T Matschke, Jennifer A Kimberly C WintonLee, et al.
Pharmaceutics|April 11, 2020
Pharmacokinetic Models to Characterize the Absorption Phase and the Influence of a Proton Pump Inhibitor on the Overall Exposure of DacomitinibAna Ruiz-Garcia, Weiwei Tan, Jerry Li, et al.
The American Journal of Surgical Pathology|February 12, 2020
Integrin β4 Is an Effective and Efficient Marker in Synchronously Highlighting Lymphatic and Blood Vascular Invasion, and Perineural Aggression in MalignancyJian Li, Yi Jiang, Cuimin Chen, et al.
Frontiers in Public Health|November 25, 2024
Antibiotic exposure and risk of overweight/obesity in children: a biomonitoring-based study from eastern Jiangsu, ChinaHuamin Sun, Jianping Huang, Yijing Zhou, et al.
Bioactive Materials|October 27, 2025
Wisdom across interfaces: Adhesion mechanism and application potential of wet-adhesive hydrogel in periodontal tissueQinyu Duan, Xueyu Wang, Shan Wang, et al.
Clinical Therapeutics|January 20, 2026
The Effect of Itraconazole on the Pharmacokinetics of Vepdegestrant, a PROteolysis TArgeting Chimera Estrogen Receptor Degrader, in Healthy Adult ParticipantsLana Tran, Jennifer A Winton, Kyle T Matschke, et al.
Frontiers in Public Health|September 22, 2025
Prevalence of inappropriate use behaviors of antibiotics and related factors among parents in eastern China: an online cross-sectional surveyHuamin Sun, Zhenyu Wang, Jianping Huang, et al.
Oncology Reports|September 13, 2013
Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastasesChunyang Zhao, Yan Xu, Yongqiang Zhang, et al.
The Prostate|March 13, 2014
Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancerChunni Wang, Lin Wang, Bo Su, et al.
Pageof 8